Companies / PhaseBio Pharmaceuticals Inc
PhaseBio Pharmaceuticals Inc
PHASCIK 1169245
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Oct 25, 2022 | New Enterprise Associates 13 LP 10% owner | Sell Open-market sale | Common Stock | $262.3K | -1.8M -26.86% | 4,857,525 | medium |
| Nov 5, 2021 | Hutson Nancy J Director | Exercise Option exercise | Common Stock | $56.2K | +25K | 24,860 | low |
| Aug 18, 2021 | Thorp Clay Director | Buy Open-market buy | Common Stock | $30.0K | +10K +43.59% | 32,943 | low |
| Nov 3, 2021 | Mow Jonathan P CEO | Exercise Option exercise | Common Stock | $24.8K | +20K +13.62% | 166,850 | low |
| Aug 27, 2021 | Mow Jonathan P CEO | Exercise Option exercise | Common Stock | $24.8K | +20K +15.77% | 146,850 | low |
| Nov 8, 2021 | Hutson Nancy J Director | Exercise Option exercise | Common Stock | $23.3K | +7K +28.07% | 33,760 | low |
| May 20, 2021 | Arnold Susan Elizabeth Executive | Grant Grant or award | Common Stock | $14.7K | +5K +29.23% | 23,241 | low |
| Nov 19, 2021 | Burkhardt Glen Executive | Sell Open-market sale | Common Stock | $13.7K | -6K -100.00% | 0 | low |